Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 5
1970 6
1971 7
1972 3
1973 2
1974 7
1975 9
1976 6
1977 7
1978 8
1979 10
1980 19
1981 15
1982 12
1983 13
1984 31
1985 26
1986 27
1987 36
1988 26
1989 26
1990 21
1991 19
1992 22
1993 35
1994 40
1995 33
1996 46
1997 32
1998 34
1999 22
2000 32
2001 24
2002 28
2003 26
2004 12
2005 15
2006 16
2007 27
2008 24
2009 15
2010 16
2011 14
2012 13
2013 15
2014 4
2015 4
2016 1
2017 8
2018 7
2019 2
2020 5
2021 8
2022 8
2023 2
2024 2
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

911 results

Results by year

Filters applied: . Clear all
Page 1
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators. Cortes JE, et al. Among authors: goldman jm. N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1. N Engl J Med. 2013. PMID: 24180494 Free PMC article. Clinical Trial.
Ponatinib for chronic myeloid leukemia.
Goldman JM. Goldman JM. N Engl J Med. 2012 Nov 29;367(22):2148-9. doi: 10.1056/NEJMe1210796. N Engl J Med. 2012. PMID: 23190226 No abstract available.
Tuberculosis and poverty.
Kearney MT, Warklyn PD, Teale C, Goldman JM, Pearson SB. Kearney MT, et al. Among authors: goldman jm. BMJ. 1993 Oct 30;307(6912):1143. doi: 10.1136/bmj.307.6912.1143. BMJ. 1993. PMID: 8110253 Free PMC article. No abstract available.
Chronic myeloid leukemia--some topical issues.
Mughal T, Cortes J, Cross NC, Donato N, Hantschel O, Jabbour E, Kantarjian H, Melo JV, Skorski T, Silver RT, Goldman JM. Mughal T, et al. Among authors: goldman jm. Leukemia. 2007 Jul;21(7):1347-52. doi: 10.1038/sj.leu.2404733. Epub 2007 May 10. Leukemia. 2007. PMID: 17495971 Review. No abstract available.
Trimethoprim-sulfamethoxazole and hyponatremia.
Ahn YH, Goldman JM. Ahn YH, et al. Among authors: goldman jm. Ann Intern Med. 1985 Jul;103(1):161-2. doi: 10.7326/0003-4819-103-1-161_3. Ann Intern Med. 1985. PMID: 3873890 No abstract available.
In Response.
Goldman JM. Goldman JM. Anesth Analg. 2017 Aug;125(2):707-708. doi: 10.1213/ANE.0000000000002246. Anesth Analg. 2017. PMID: 28654431 No abstract available.
What challenges remain in chronic myeloid leukemia research?
Carella AM, Branford S, Deininger M, Mahon FX, Saglio G, Eiring A, Khorashad J, O'Hare T, Goldman JM. Carella AM, et al. Among authors: goldman jm. Haematologica. 2013 Aug;98(8):1168-72. doi: 10.3324/haematol.2013.090381. Haematologica. 2013. PMID: 23904234 Free PMC article. No abstract available.
Chronic myeloid leukemia.
Deininger MW, Goldman JM. Deininger MW, et al. Among authors: goldman jm. Curr Opin Hematol. 1998 Jul;5(4):302-8. doi: 10.1097/00062752-199807000-00010. Curr Opin Hematol. 1998. PMID: 9747637 Review.
Advances in CML.
Goldman JM. Goldman JM. Clin Adv Hematol Oncol. 2007 Apr;5(4):270-2, 292. Clin Adv Hematol Oncol. 2007. PMID: 17607286 Review. No abstract available.
911 results